Methyl 5-acetoxyhexanoate
Common Name: |
Methyl 5-acetoxyhexanoate |
IUPAC Name: |
methyl 5-acetyloxyhexanoate |
Molecular Formula: |
C6H14OS |
SMILES: |
CC(CCCC(=O)OC)OC(=O)C |
Inchi: |
1S/C9H16O4/c1-7(13-8(2)10)5-4-6-9(11)12-3/h7H,4-6H2,1-3H3 |
Inchi Key: |
XZGQJRXRXRYNRI-UHFFFAOYSA-N |
Cas No: |
35234-22-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
134.24 |
Mass (g/mol) |
188.105 |
Molar Refractivity |
40.01 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
3 |
Rings |
|
TPSA |
48.03 |
Hetero Atoms |
4 |
Heavy Atoms |
8 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
194.00 to 195.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.08 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
1.281 |
iLOGP |
2.15 |
XLOGP3 |
1.34 |
WLOGP |
1.73 |
MLOGP |
1.53 |
ESOL Log S |
-1.32 |
ESOL Solubility (mg/ml) |
6.45 |
ESOL Solubility (mol/l) |
0.048 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.95 |
Ali Solubility (mg/ml) |
1.5 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.72 |
Silicos-IT Solubility (mg/ml) |
2.57 |
Silicos-IT Solubility (mol/l) |
0.02 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.17 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.341 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.771 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |